Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 1.1 Underwriting Agreement
- 2.1 Asset Purchase Agreement
- 2.2 Assest Contribution and Exchange Agreement
- 2.3 Stock Contribution and Exchange Agreement
- 2.4 Asset Contribution and Exchange Agreement
- 2.5 Stock Contribution and Exchange Agreement
- 2.6 Asset Contribution and Exchange Agreement
- 2.7 Asset Contribution
- 2.8 Asset Purchase Agreement
- 2.9 Agreement and Plan of Merger
- 2.10 Agreement and Plan of Merger
- 2.12 Agreement and Plan of Merger
- 3.1 Restated Certificate of Incorporation
- 3.2 Amended and Restated By-laws
- 4.1 Certificate
- 5.1 Opinion of Jenkens & Gilchrist Chapin LLP
- 10.12 Form of Option Contract BTWN Registrant & Officer
- 10.15 Employee Stock Purchase Plan
- 10.22 Employment Agreement BTWN Richard Effress
- 10.23 Employment Agreement BTWN Joseph Caffarelli
- 10.24 Employment Agreement BTWN Dan Croteau
- 10.25 Employment Agreement BTWN Jim Drill
- 10.26 Employment Agreement BTWN Douglas Woodruff
- 10.27 Employment Agreement BTWN Rick Mcwhorter
- 10.28 Employment Agreement BTWN Ralph Polumbo
- 10.29 Employment Agreement BTWN Rich Snider
- 10.33 Office/tech Lease Dated 3/30/99
- 10.34 Lease Agreement
- 10.35 Kidd Management Services Agreement
- 10.36 Closing Fee Agreement
- 10.37 Whitney Management Services Agreement
- 10.38 Promissory Note
- 10.39 Amended Certificate of Designation
- 10.40 Management Bonus Plan Description
- 23.1 Consent of Ernst & Young LLP
- 23.2 Consent of Bertram, Vallez, Kaplan & Talbot, LTD.
- 23.3 Consent of James F. Yochum, Cpa
- 23.4 Consent of Pricewaterhousecoopers LLP
- 23.5 Consent of Grant Thornton, LLP
MEDT similar filings
Filing view
External links
Exhibit 23.5
CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS
We have issued our report dated February 9, 2001, accompanying the financial statements of ACT Medical, Inc. contained in Amendment No. 2 to the Registration Statement and Prospectus of MedSource Technologies, Inc. We consent to the use of the aforementioned report in Amendment No. 3 to the Registration Statement and Prospectus, and to the use of our name as it appears under the caption “Experts.”
/s/ Grant Thornton LLP
Boston, Massachusetts
March 18, 2002